3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase EARLY_PHASE1
1
Phase 2/3
1
Phase 2
1
Status
Unknown
13
Recruiting
6
Completed
5
Terminated
4
Not yet recruiting
3
Active not recruiting
2
Suspended
1
Sponsor Class
OTHER
4
Study Type
Interventional
4
Sponsor
Cancer Type
Gastrointestinal
4
Gynecologic
3
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Conditions
Stomach Neoplasms
4
Peritoneal Neoplasms
4
Ovarian Neoplasms
3
Fallopian Tube Neoplasms
3
Sarcoma
1
Rhabdomyosarcoma
1
Recurrence
1
Rectal Neoplasms
1
Peritoneal Metastases From Gastric Cancer
1
Peritoneal Metastases From Colorectal Cancer
1
Pelvic Neoplasms
1
Mesothelioma, Malignant
1
Liposarcoma
1
Hyperthermia
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
Capecitabine
27
pembrolizumab
19
Oxaliplatin
19
Fluorouracil
17
Cisplatin
17
Trastuzumab
14
Docetaxel
14
Leucovorin
11
Paclitaxel
8
Irinotecan
8
S 1 (combination)
7
Epirubicin
6
Cyclophosphamide
5
tegafur-gimeracil-oteracil
4
aldesleukin
4
Hyperthermic Intraperitoneal Chemotherapy
4
titanium silicide
3
spartalizumab
3
fludarabine phosphate
3
fludarabine
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Ramucirumab
3
Nivolumab
3
Indocyanine Green
3
Gemcitabine
3
Carboplatin
3
Albumin-Bound Paclitaxel
3
Ado-Trastuzumab Emtansine
3
vistusertib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Terminated
×
Stomach Neoplasms
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled
NCT02969122
2024-09-19
Cy-plus
Peking University
Phase NA
Terminated
59 enrolled
NCT03150628
2019-04-17
CISCA
UMC Utrecht
Phase 2
Terminated
3 enrolled
NCT01683864
2018-01-30
HIPECStomach
University Hospital Tuebingen
Phase 2/3
Terminated
3 enrolled